| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.053 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |